CBD for Schizophrenia: This recent article in the March, 2012 issue of Translational Psychiatry reports on a double-blind, randomized clinical trial of cannabidiol vs amisulpride, a potent antipsychotic, in acute schizophrenia to evaluate the clinical relevance of initial findings. Either treatment was safe and led to significant clinical improvement, but cannabidiol displayed a markedly superior side effect profile. Read More
University of Saskatchewan researchers have discovered a cannabis ‘pharma factory’, never before seen in plants. “What cannabis has done is take a rare fatty acid with a simple, six-carbon chain and use it as a building block to make something chemically complex and pharmacologically active.” Read More
Taxol is a common chemotherapy agent that is a mitotic inhibitor. It is used to treat patients with lung, ovarian, breast, head & neck cancer and advanced forms of Kaposi’s sarcoma. One of the painful side effects of this agent is neuropathy, a side effect that can limit the effective use of the drug. This article shows promise in using CBD to help prevent the neuropathy caused by Taxol. Read More
To date, a large number of controlled clinical trials have been done evaluating the therapeutic applications of cannabis and cannabis-based preparations. This current review reports on the more recent clinical data available.
Sean McAllister, PhD, who has been studying the anti-cancer effects of cannabinoids in the laboratory (on a grant from NIH and with a license from the DEA). The occasion was the winter meeting of the Society of Cannabis Clinicians.”That’s a very good question,” McAllister would say…and provide the answer, and tie it back into his main thread. Read More
Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD) and other components of the Cannabis plant. It was conceived by two journalists who have been covering the medical cannabis movement / industry in the pages of O’Shaughnessy’s Journal of Cannabis in Clinical Practice. Read More